|
|
|
|
Syros Pharmaceuticals Inc (NASDAQ: SYRS) |
|
|
|
| |
Syros Pharmaceuticals Inc Accounts Receivables Turnover Ratio from the third quarter 2024 to the third quarter 2023
Quarterly Results, Trends, Rankings, Statistics
|
Select the Comparisons :
|
|
Select the Ratio:
|
Accounts Receivables Turnover▼
|
Accounts Receivables Turnover▼
|
| SYRS Receivables Turnover Ratio |
(Sep 30 2024)
III. Quarter |
(Jun 30 2024)
II. Quarter |
(Mar 31 2024)
I. Quarter |
(Dec 31 2023)
IV. Quarter |
(Sep 30 2023)
III. Quarter |
| Y / Y Receivable Change |
- |
- |
- |
- |
- |
| Y / Y Revenue Change |
- |
- |
- |
- |
-3.32 % |
| Receivable Turnover Ratio (TTM) |
- |
9.97 |
8.16 |
7.66 |
6.78 |
| SYRS's Total
Ranking |
# |
# |
# |
# |
# |
| Accounts Receivable average collection period days |
- |
37 |
45 |
48 |
54 |
| Seq. Receivable Change |
- |
- |
- |
- |
-5.18 % |
| Seq. Revenue Change |
- |
- |
- |
-89.71 % |
32.79 % |
| Receivable Turnover Ratio Statistics |
| High |
Average |
Low |
| 0 |
0 |
0 |
|
|
|
| Companies with similar Receivables Turnover Ratio for the quarter ending Sep 30 2024, within Healthcare Sector | Receivable Turnover Ratio | Revenues for 12 Months ending Sep 30 2024 | Receivable at quarter ending Sep 30 2024 |
|
Date modified: 2024-12-29T19:28:16+00:00
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
